Featured Research

from universities, journals, and other organizations

New Study Aims To Halt The Progression Of Multiple Sclerosis

Date:
April 8, 2008
Source:
Wesley Research Institute
Summary:
A new research study aims to stop the progression of early active stage multiple sclerosis in its tracks. There are currently more than 2.5 million people worldwide with MS, a chronic disease that affects the central nervous system.

A new research study being conducted at The Wesley Research Institute (WRI) aims to stop the progression of early active stage Multiple Sclerosis (MS) in its tracks.

Related Articles


There are currently more than 2.5 million people worldwide with MS, a chronic disease that affects the central nervous system.

They suffer from a range of debilitating symptoms including impaired gait and mobility, bladder and bowel dysfunction, cognitive and visual impairment, and profound muscle weakness.

Principal Investigator of the project at the WRI, Dr Pamela McCombe, is a neurologist at both The Wesley Hospital and Royal Brisbane and Women's Hospital, and also Chairman of the WRI Research Committee. She said "This study might prove to be the strongest, most effective treatment of MS ever."

"Current treatments for MS only reduce the progression rate of the disease. This new treatment, if successful, will actually halt the progression of MS. Not only does it aim to stop MS in its tracks but it will also spare MS sufferers from weekly injections replacing them with infusions over three consecutive days every year."

She added, "The medication targets lymphocytes (a type of white blood cell) to decrease the inflammatory reaction responsible for the progression of MS."

Preliminary studies have demonstrated that as a result of this medication sufferers have experienced fewer disease relapses, a decrease in the formation of central nervous system lesions and a reduction in cumulative disabilities. "This suggests to me that there is every chance this medication will prove successful and become widely used."

This is an international study involving 200 sites. The WRI is one of fifteen sites in Australia to trial this new treatment, and one of only two in Queensland. The other site is the Gold Coast Hospital.


Story Source:

The above story is based on materials provided by Wesley Research Institute. Note: Materials may be edited for content and length.


Cite This Page:

Wesley Research Institute. "New Study Aims To Halt The Progression Of Multiple Sclerosis." ScienceDaily. ScienceDaily, 8 April 2008. <www.sciencedaily.com/releases/2008/04/080404114459.htm>.
Wesley Research Institute. (2008, April 8). New Study Aims To Halt The Progression Of Multiple Sclerosis. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2008/04/080404114459.htm
Wesley Research Institute. "New Study Aims To Halt The Progression Of Multiple Sclerosis." ScienceDaily. www.sciencedaily.com/releases/2008/04/080404114459.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins